News
Ashland, Inc.: Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range
Sales of $463 million, down 15 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results